Postoperative Analgesia by Epidural vs IV Ketamine Concurrent With Caudal Anesthesia in Pediatric Orthopedic Surgery
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00532662 |
Recruitment Status : Unknown
Verified November 2010 by Tehran University of Medical Sciences.
Recruitment status was: Recruiting
First Posted : September 20, 2007
Last Update Posted : November 18, 2010
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Analgesia | Drug: S(+)-ketamine | Phase 4 |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 40 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Care Provider) |
Primary Purpose: | Treatment |
Official Title: | Intravenous Versus Caudal Supplementation of Ketamine for Postoperative Pain Control in Children,A Double-blind Controlled Clinical Trial. |
Study Start Date : | November 2007 |
Estimated Primary Completion Date : | June 2009 |
Estimated Study Completion Date : | July 2009 |

Arm | Intervention/treatment |
---|---|
Experimental: 1
epidural s(+)-ketamine for supplementation of caudal anesthesia
|
Drug: S(+)-ketamine
epidural or intravenous 1 mg kg-1 once concurrent with caudal anesthesia |
Active Comparator: 2
intravenous ketamine for supplementation of caudal anesthesia
|
Drug: S(+)-ketamine
epidural or intravenous 1 mg kg-1 once concurrent with caudal anesthesia |
- pain score [ Time Frame: 24 hours after anesthesia ]
- analgesic request [ Time Frame: 24 hours after anesthesia ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | up to 12 Years (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Children aged < = 12 years
- Children scheduled for elective orthopedic surgery with caudal block
- ASA score < = 3
Exclusion Criteria:
- Contraindication for caudal block such as vertebral defect or infection at the site of block
- Disagreement of parents
- Patient's age > 12 years
- ASA score > = 4

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00532662
Contact: Hamid Reza Amiri, MD | 021-61192628 | hramiri@gmail.com |
Iran, Islamic Republic of | |
orthopedic ward of Imam Khomeini hospital | Recruiting |
Tehran, Iran, Islamic Republic of, 1419733141 | |
Contact: Ramin Espandar, MD 02161192627 espandarmd@sina.tums.ac.ir | |
orthopedic surgery room- Imam Khomeini hospital | Recruiting |
Tehran, Iran, Islamic Republic of | |
Contact: Siamak Yousef Sibdari, MD 021-61192627 sibdari@gmail.com |
Study Chair: | Ramin Espandar, MD | Imam Khomeini hospital- tehran university of medical sciences |
Responsible Party: | HamidReza Amiri/Assistant professor, TehranUMS |
ClinicalTrials.gov Identifier: | NCT00532662 |
Other Study ID Numbers: |
86-02-78-56790 |
First Posted: | September 20, 2007 Key Record Dates |
Last Update Posted: | November 18, 2010 |
Last Verified: | November 2010 |
Epidural Intravenous Ketamine Analgesia |
Caudal Pediatric Regional Local Anesthetics |
Agnosia Perceptual Disorders Neurobehavioral Manifestations Neurologic Manifestations Nervous System Diseases Ketamine Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs |
Anesthetics, Dissociative Anesthetics, Intravenous Anesthetics, General Anesthetics Central Nervous System Depressants Excitatory Amino Acid Antagonists Excitatory Amino Acid Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action |